The REDCap Forms Training Session will teach users to build forms using the online designer or data dictionary (lecture/demo).

Our current REDCap trainings are offered as webinar-only.

Register

About REDCap

REDCap is a secure web application that can be used to build and manage case report forms, surveys and other data capture mechanisms for clinical research. NC TraCS provides training classes to assist you in getting started with building REDCap data collection forms for your research projects.

Current REDCap training offerings include:

1. Forms (beginner)
2. Forms: Hands On (beginner)
3. Functions (advanced)
4. Open Session (Surveys and general questions)
5. Clinical Data Management (3-day)

For more information, please visit our REDCap webpage.

MURAL Multilingual Research Capacity Building Lecture Series: Working with professional interpreters, translators, and research participants who speak primary languages other than English

Learn about the importance of collaborating with qualified interpreters and translators when designing and implementing health research studies with speakers of languages other than English.

Join the Multilingual Research Advancement for Health (MURAL) program and Myriam Peereboom, MBA/MHA, CMI, CHITM, for the third edition of the Fall 2020 MURAL Multilingual Research Capacity Building Lecture Series. Peereboom will detail the roles and modes of interpreters and different local resources available for reaching qualified interpreters. She will also present case studies in which the lack of adequate protocols for ensuring quality language interpreting resulted in medical errors. Finally, she will present some lessons learned to keep in mind when working with interpreters and translators.

Presenter
Myriam Peereboom, MBA/MHA, CMI, CHITM
Education Specialist, Interpreter Services
UNC Health

Register

Coronavirus Conversations - On The Ground: Inside the COVID-19 Vaccine Trials

Ten months into the pandemic, the research community is making rapid progress toward developing a safe and effective COVID-19 vaccine, with several vaccines in Phase 3 trials in the US alone. Despite this remarkable speed, concerned citizens and members of the medical and public health communities naturally have questions: What does it mean about overall safety and effectiveness that some projects have been paused to ensure the safety and health of vaccine trial participants? Who has been included in the trial process, and how representative are they of our society? When the first vaccines are found to be safe and effective, how effective can we expect them to be, based on current indications?

Join Duke Science & Society and their guests, who are overseeing COVID-19 vaccine trials for Moderna and Pfizer, in a discussion of how the COVID-19 vaccine trials are progressing in the U.S, what current indications are about their safety and efficacy, and when we can expect initial approvals for early or limited use.

Moderator
Nita Farahany, JD, PhD, Director, Duke Initiative For Science & Society
Duke University

Panelists

Cindy Gay, MD, MPH, Principal Investigator, Moderna SARS-COV-2 vaccine trial
University of North Carolina at Chapel Hill

Emmanuel Walter, MD, Principal Investigator, Pfizer SARS-COV-2 vaccine trial
Duke University

Register